We did not establish any correlation between SLAMF1 expression levels and disease activity or specific disease manifestations in our cohort of SLE patients, although a higher number of study subjects may be needed in order to be able to draw any definitive conclusions with respect to clinical implications. Here, SLAMF1 is linked to systemic lupus erythematosus.